UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial

Journal of Alzheimer's disease, 2017-01, Vol.57 (4), p.1325-1334

2017

Volltextzugriff (PDF)

Functions of reminiscence and the psychological well-being of young-old and older adults over time

Aging & mental health, 2011-03, Vol.15 (2), p.272-281

2011

Volltextzugriff (PDF)

Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study

BMC psychiatry, 2021-10, Vol.21 (1), p.1-492, Article 492

2021

Volltextzugriff (PDF)

Deconstructing racial differences: the effects of quality of education and cerebrovascular risk factors

The journals of gerontology. Series B, Psychological sciences and social sciences, 2015-07, Vol.70 (4), p.545-556

2015

Volltextzugriff (PDF)

Happiness, Creative Ideation, and Locus of Control

Creativity research journal, 2008-01, Vol.20 (1), p.67-71

2008

Volltextzugriff (PDF)

Developmental Trends in the Creativity of School-Age Children

Creativity research journal, 2005-10, Vol.17 (4), p.327-335

2005

Volltextzugriff (PDF)

Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia

Journal of Alzheimer's disease, 2015-01, Vol.44 (3), p.897-906

2015

Volltextzugriff (PDF)

Safety and Tolerability of Aripiprazole Lauroxil 2-Month Formulation With 1-Day Initiation for Treatment of Schizophrenia in the ALPINE Study

CNS spectrums, 2021-04, Vol.26 (2), p.158-159

2021

Volltextzugriff (PDF)

S195. Improvement in Prolactin and Sexual Side Effects in Patients With Schizophrenia Who Switched From Paliperidone Palmitate or Risperidone Long-Acting Injectable to Aripiprazole Lauroxil

Biological psychiatry (1969), 2019-05, Vol.85 (10), p.S373-S373

2019

Volltextzugriff (PDF)

No Fun Anymore: Leisure and Marital Quality Across the Transition to Parenthood

Journal of marriage and family, 2008-02, Vol.70 (1), p.28-43

2008

Volltextzugriff (PDF)

F2. CHANGE IN PROLACTIN AND SEXUAL SIDE EFFECTS IN PATIENTS WITH SCHIZOPHRENIA WHO SWITCHED FROM PALIPERIDONE PALMITATE OR RISPERIDONE LONG-ACTING INJECTION TO ARIPIPRAZOLE LAUROXIL

Schizophrenia bulletin, 2019-04, Vol.45 (Supplement_2), p.S255-S255

2019

Volltextzugriff (PDF)

Beyond 52-Week Long-Term Safety: Long-Term Outcomes of Aripiprazole Lauroxil for Patients With Schizophrenia Continuing in an Extension Study

The journal of clinical psychiatry, 2020-08, Vol.81 (5)

2020

Volltextzugriff (PDF)

412. Efficacy of Karxt on Negative Symptoms in Acute Schizophrenia: A Post Hoc Analysis of Participants With Prominent Negative Symptoms

Biological psychiatry (1969), 2024-05, Vol.95 (10), p.S268-S269

2024

Volltextzugriff (PDF)

Analysis of prolactin and sexual side effects in patients with schizophrenia who switched from paliperidone palmitate to aripiprazole lauroxil

Psychiatry research, 2021-08, Vol.302, p.114030-114030, Article 114030

2021

Volltextzugriff (PDF)

Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trials

Schizophrenia research, 2024-12, Vol.274, p.57-65

2024

Volltextzugriff (PDF)

M105. ACTIGRAPHIC MONITORING OF SLEEP-WAKE CYCLE IN SCHIZOPHRENIA OUTPATIENTS RECEIVING A LONG-ACTING INJECTABLE ANTIPSYCHOTIC: FEASIBILITY AND INITIAL RESULTS FROM A PROSPECTIVE RCT

Schizophrenia bulletin, 2020-05, Vol.46 (Supplement_1), p.S175-S175

2020

Volltextzugriff (PDF)

A Comparison of Volatile Anesthesia and Total Intravenous Anesthesia (TIVA) Effects on Outcome From Cardiac Surgery: A Systematic Review and Meta-Analysis

Journal of cardiothoracic and vascular anesthesia, 2021-04, Vol.35 (4), p.1096-1105

2021

Volltextzugriff (PDF)

Efficacy and Safety of a 2-Month Formulation of Aripiprazole Lauroxil With 1-Day Initiation in Patients Hospitalized for Acute Schizophrenia Transitioned to Outpatient Care: Phase 3, Randomized, Double-Blind, Active-Control ALPINE Study

The journal of clinical psychiatry, 2020-05, Vol.81 (3)

2020

Volltextzugriff (PDF)

Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease

Journal of Alzheimer's disease, 2013-01, Vol.35 (4), p.789-797

2013

Volltextzugriff (PDF)

Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder

Neuropsychopharmacology (New York, N.Y.), 2019-12, Vol.44 (13), p.2268-2276

2019

Volltextzugriff (PDF)

Functioning and Cognition in Patients with Schizophrenia After Initiating Treatment with Aripiprazole Lauroxil: Secondary Outcomes and Post Hoc Analysis

Innovations in clinical neuroscience, 2024-01, Vol.21 (1-3), p.43-51

2024

Volltextzugriff (PDF)

167 Randomized, Double-Blind, Active-Controlled Study of Starting Aripiprazole Lauroxil with 1-Day Initiation in Acutely Ill Patients with Schizophrenia

CNS spectrums, 2020-04, Vol.25 (2), p.306-307

2020

Volltextzugriff (PDF)

Aripiprazole Lauroxil 2-Month Formulation With 1-Day Initiation for Acute Schizophrenia: ALPINE Exploratory Efficacy and Patient-Reported Outcomes

CNS spectrums, 2021-04, Vol.26 (2), p.171-172

2021

Volltextzugriff (PDF)

Switching patients with schizophrenia from paliperidone palmitate to aripiprazole lauroxil: A 6-month, prospective, open-label study

Schizophrenia research, 2019-06, Vol.208, p.44-48

2019

Volltextzugriff (PDF)

Changes in Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics (LAIs), Including Telepsychiatry Use, During the COVID-19 Pandemic

Neuropsychiatric disease and treatment, 2023-01, Vol.19, p.623-634

2023

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Englisch
(69)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial

Functions of reminiscence and the psychological well-being of young-old and older adults over time

Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study

Deconstructing racial differences: the effects of quality of education and cerebrovascular risk factors

Happiness, Creative Ideation, and Locus of Control

Developmental Trends in the Creativity of School-Age Children

Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia

Safety and Tolerability of Aripiprazole Lauroxil 2-Month Formulation With 1-Day Initiation for Treatment of Schizophrenia in the ALPINE Study

S195. Improvement in Prolactin and Sexual Side Effects in Patients With Schizophrenia Who Switched From Paliperidone Palmitate or Risperidone Long-Acting Injectable to Aripiprazole Lauroxil

No Fun Anymore: Leisure and Marital Quality Across the Transition to Parenthood

F2. CHANGE IN PROLACTIN AND SEXUAL SIDE EFFECTS IN PATIENTS WITH SCHIZOPHRENIA WHO SWITCHED FROM PALIPERIDONE PALMITATE OR RISPERIDONE LONG-ACTING INJECTION TO ARIPIPRAZOLE LAUROXIL

Beyond 52-Week Long-Term Safety: Long-Term Outcomes of Aripiprazole Lauroxil for Patients With Schizophrenia Continuing in an Extension Study

412. Efficacy of Karxt on Negative Symptoms in Acute Schizophrenia: A Post Hoc Analysis of Participants With Prominent Negative Symptoms

Analysis of prolactin and sexual side effects in patients with schizophrenia who switched from paliperidone palmitate to aripiprazole lauroxil

Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trials

M105. ACTIGRAPHIC MONITORING OF SLEEP-WAKE CYCLE IN SCHIZOPHRENIA OUTPATIENTS RECEIVING A LONG-ACTING INJECTABLE ANTIPSYCHOTIC: FEASIBILITY AND INITIAL RESULTS FROM A PROSPECTIVE RCT

A Comparison of Volatile Anesthesia and Total Intravenous Anesthesia (TIVA) Effects on Outcome From Cardiac Surgery: A Systematic Review and Meta-Analysis

Efficacy and Safety of a 2-Month Formulation of Aripiprazole Lauroxil With 1-Day Initiation in Patients Hospitalized for Acute Schizophrenia Transitioned to Outpatient Care: Phase 3, Randomized, Double-Blind, Active-Control ALPINE Study

Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease

Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder

Functioning and Cognition in Patients with Schizophrenia After Initiating Treatment with Aripiprazole Lauroxil: Secondary Outcomes and Post Hoc Analysis

167 Randomized, Double-Blind, Active-Controlled Study of Starting Aripiprazole Lauroxil with 1-Day Initiation in Acutely Ill Patients with Schizophrenia

Aripiprazole Lauroxil 2-Month Formulation With 1-Day Initiation for Acute Schizophrenia: ALPINE Exploratory Efficacy and Patient-Reported Outcomes

Switching patients with schizophrenia from paliperidone palmitate to aripiprazole lauroxil: A 6-month, prospective, open-label study

Changes in Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics (LAIs), Including Telepsychiatry Use, During the COVID-19 Pandemic

Suchergebnisse filtern